Landos Biopharma Inc is a biotechnology business based in the US. Landos Biopharma Inc shares (LABP) are listed on the NASDAQ and all prices are listed in US Dollars. Landos Biopharma Inc employs 19 staff and has a market cap (total outstanding shares value) of 0.00.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – LABP.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Landos Biopharma Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Landos Biopharma Inc stock price (NASDAQ: LABP)
Use our graph to track the performance of LABP stocks over time.
Is it a good time to buy Landos Biopharma Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Landos Biopharma Inc financials
Gross profit TTM
$18 million
Return on assets TTM
-39.38%
Return on equity TTM
-70.67%
Profit margin
0%
Book value
$7.43
Market Capitalization
$71.7 million
TTM: trailing 12 months
Landos Biopharma Inc share dividends
We're not expecting Landos Biopharma Inc to pay a dividend over the next 12 months.
You may also wish to consider:
Have Landos Biopharma Inc's shares ever split?
Landos Biopharma Inc's shares were
split on a 1:10 basis on 25 May 2023
. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Landos Biopharma Inc shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Landos Biopharma Inc shares which in turn could have impacted Landos Biopharma Inc's share price.
Landos Biopharma Inc share price volatility
Over the last 12 months, Landos Biopharma Inc's shares have ranged in value from as little as $6.31 up to $22.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Landos Biopharma Inc's is 0.143. This would suggest that Landos Biopharma Inc's shares are less volatile than average (for this exchange).
To put Landos Biopharma Inc's beta into context you can compare it against those of similar companies.
Landos Biopharma, Inc. , a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate is NX-13, an oral gut-selective Nucleotide Oligomerization Domain (NLRX1), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines that is in Phase 2 clinical trial to treat ulcerative colitis (UC) and completed Phase 1 to treat Crohn's disease (CD). The company's preclinical candidates in development include LABP-73, an oral and small molecule NLRX1 pathway agonist for the treatment of asthma and eosinophilic disorders; LABP-66 is an oral and small molecule NLRX1 pathway agonist for the treatment of multiple sclerosis and neurodegenerative disorders; and LABP-69, an oral PLXDC2 agonist for the treatment of rheumatoid arthritis, UC, and CD. The company has a license and collaboration agreement with LianBio Respiratory Limited to develop, manufacture, and commercialize omilancor and NX-13. Landos Biopharma, Inc. was incorporated in 2017 and is headquartered in Blacksburg, Virginia.
Frequently asked questions
What percentage of Landos Biopharma Inc is owned by insiders or institutions? Currently 9.888% of Landos Biopharma Inc shares are held by insiders and 52.041% by institutions.How many people work for Landos Biopharma Inc? Latest data suggests 19 work at Landos Biopharma Inc.When does the fiscal year end for Landos Biopharma Inc? Landos Biopharma Inc's fiscal year ends in December.Where is Landos Biopharma Inc based? Landos Biopharma Inc's address is: 1800 Kraft Drive, Blacksburg, VA, United States, 24060What is Landos Biopharma Inc's ISIN number? Landos Biopharma Inc's international securities identification number is: US5150691021What is Landos Biopharma Inc's CUSIP number? Landos Biopharma Inc's Committee on Uniform Securities Identification Procedures number is: 515069102
Check out the best-performing ETFs so far in 2025.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
